Companies:
53,204
Total Market Cap:
167399002169802.37
VYNE Therapeutics
NASDAQ: VYNE
Healthcare
Biotechnology
Global Rank
#38055
Country Rank
#4914
Market Cap
19.05 M
Price
28.56
Change (%)
12.22%
Volume
93,293
VYNE Therapeutics's latest marketcap:
19.05 M
As of 07/28/2026, VYNE Therapeutics's market capitalization has reached $19.05 M. According to our data, VYNE Therapeutics is the 38055th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 19.05 M |
| Revenue (ttm) | 454,000 |
| Net Income (ttm) | -21,457,000 |
| Shares Out | 667,057 |
| EPS (ttm) | -25.07 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 07/24/2026 |
| Earnings Date | 08/13/2026 |
Market Cap Chart
Data Updated: 07/28/2026
VYNE Therapeutics's yearly market capitalization.
VYNE Therapeutics has seen its market value drop from $95.7 M to $19.05 M since 2018, representing a total decrease of 80.09% and an annual compound decline rate (CAGR) of 19.19%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/28/2026 | $19.05 M | 7.34% | 38055 |
| 12/31/2025 | $19.31 M | -60.93% | 36341 |
| 12/31/2024 | $49.42 M | 51.96% | 28064 |
| 12/29/2023 | $32.52 M | 273.57% | 30647 |
| 12/30/2022 | $8.71 M | -84.05% | 36433 |
| 12/31/2021 | $54.59 M | -79.42% | 27004 |
| 12/31/2020 | $265.2 M | 138.27% | 15231 |
| 12/31/2019 | $111.3 M | 16.3% | n/a |
| 12/31/2018 | $95.7 M | n/a |
Company Profile
VYNE Therapeutics was founded in 2003 in United States.
The company went public on 01/25/2018
on the Nasdaq Stock Market.
With 10 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is VYNE Therapeutics's (VYNE) current market cap?As of 07/28/2026, VYNE Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $19.05 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does VYNE Therapeutics (VYNE) rank globally by market cap?VYNE Therapeutics global market capitalization ranking is approximately 38055 as of 07/28/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.